Shushant Jain

Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.

Assessment of a DJ-1 (PARK7) polymorphism in Finnish PD.

Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.

Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.

Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.

A common LRRK2 mutation in idiopathic Parkinson's disease.

Clinical and positron emission tomography of Parkinson's disease caused by LRRK2.

Molecular genetic pathways in Parkinson's disease: a review.

Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.

Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.

Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD.

The R1441C mutation of LRRK2 disrupts GTP hydrolysis.

Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation.

The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation.

From single genes to gene networks: high-throughput-high-content screening for neurological disease.

SFRS7-mediated splicing of tau exon 10 is directly regulated by STOX1A in glial cells.

The complete automation of cell culture: improvements for high-throughput and high-content screening.